Michael Donegan
2018
In 2018, Michael Donegan earned a total compensation of $703.5K as Vice President - Finance at TherapeuticsMD, a 32% increase compared to previous year.
Compensation breakdown
| Bonus | $18,125 |
|---|---|
| Non-Equity Incentive Plan | $72,500 |
| Option Awards | $308,232 |
| Salary | $290,000 |
| Other | $14,623 |
| Total | $703,480 |
Donegan received $308.2K in option awards, accounting for 44% of the total pay in 2018.
Donegan also received $18.1K in bonus, $72.5K in non-equity incentive plan, $290K in salary and $14.6K in other compensation.
Rankings
In 2018, Michael Donegan's compensation ranked 10,693rd out of 14,244 executives tracked by ExecPay. In other words, Donegan earned more than 24.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,693 out of 14,244 | 25th |
Division Manufacturing | 4,311 out of 5,765 | 25th |
Major group Chemicals And Allied Products | 1,628 out of 2,128 | 24th |
Industry group Drugs | 1,377 out of 1,817 | 24th |
Industry Pharmaceutical Preparations | 1,056 out of 1,391 | 24th |
Source: SEC filing on April 29, 2019.
Donegan's colleagues
We found four more compensation records of executives who worked with Michael Donegan at TherapeuticsMD in 2018.